Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Koa Shoji Holdings CoTSE:9273 +0.91%83 ROE % is 16.50% as of Dec. 2025, which is 31% above its 10-year median of 12.57. GuruFocus rates TSE:9273 with a GF Score™ of 83/100 and a GF Value™ of 円752.97 (Fairly Valued). The stock has 1 warning sign investors should review. Among 937 Drug Manufacturers companies, Koa Shoji Holdings Co ranks better than 50.69% on this metric.
The historical rank and industry rank for Koa Shoji Holdings Co's ROE % or its related term are showing as below:
TSE:9273'
s ROE % Range Over the Past 10 Years
Min: 4.95 Med: 12.57 Max: 13.68
Current: 10.48
During the past 10 years, Koa Shoji Holdings Co's highest ROE % was 13.68%. The lowest was 4.95%. And the median was 12.57%.
TSE:9273's ROE % is ranked better than 50.69% of 937
companies
in the Drug Manufacturers industry
Industry Median: 6.04
vs TSE:9273: 10.48
Koa Shoji Holdings Co (TSE:9273) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Koa Shoji Holdings Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Koa Shoji Holdings Co ROE % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Koa Shoji Holdings Co's ROE % distribution charts can be found below:
* The bar in red indicates where Koa Shoji Holdings Co's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Koa Shoji Holdings Co (TSE:9273) has a ROE % of 16.50% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Koa Shoji Holdings Co and its competitors. This is 31% above median its historical median of 12.57. Over the past decade, Koa Shoji Holdings Co's ROE % has ranged from 4.95 to 13.68. According to the industry distribution chart, Koa Shoji Holdings Co ranks #462 out of 937 companies in the Drug Manufacturers industry, placing it in the top 49.3%.
Is Koa Shoji Holdings Co's ROE % too high?
Koa Shoji Holdings Co's current ROE % of 16.50% is 31% above median its 10-year median of 12.57. Over the past 10 years, this metric has ranged from a low of 4.95 to a high of 13.68. The Drug Manufacturers industry median ROE % is 6.04. Koa Shoji Holdings Co's value of 16.50% is 173.2% above this industry median. Based on the distribution chart, Koa Shoji Holdings Co ranks #462 out of 937 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Koa Shoji Holdings Co has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Koa Shoji Holdings Co's ROE % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Koa Shoji Holdings Co ranks #462 out of 937 companies for ROE %. This puts Koa Shoji Holdings Co in the upper half of its industry. The industry median ROE % is 6.04. Koa Shoji Holdings Co's value of 16.50% is 173.2% above this benchmark. Historically, Koa Shoji Holdings Co's own ROE % has ranged from 4.95 to 13.68 over the past decade. While the company's 10-year median is 12.57 vs. the industry median of 6.04, Koa Shoji Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Drug Manufacturers company?
The median ROE % among Drug Manufacturers companies is 6.04, based on 937 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Koa Shoji Holdings Co's current ROE % of 16.50% is 173.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Koa Shoji Holdings Co and its competitors. For the Drug Manufacturers industry, the median ROE % is 6.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Koa Shoji Holdings Co's current ROE % is 16.50%, which is 31% above median its own 10-year median of 12.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koa Shoji Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Koa Shoji Holdings Co (TSE:9273) is currently considered Fairly Valued. The stock's GF Value™ is 円752.97, compared to a current price of 円780.00 — trading 3.6% above its estimated fair value. The current ROE % is 16.50%, which is 31% above median its 10-year median of 12.57 and 173.2% above the Drug Manufacturers industry median of 6.04. Koa Shoji Holdings Co's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Koa Shoji Holdings Co (TSE:9273), the current ROE % is 16.50% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Koa Shoji Holdings Co (TSE:9273) Overvalued in 2026?
Based on GuruFocus' analysis, Koa Shoji Holdings Co stock appears to be overvalued.
The current stock price of 円780.00 is trading 3.6% above its estimated GF Value™ of 円752.97.
GuruFocus considers Koa Shoji Holdings Co to be Fairly Valued.
Key valuation signals for TSE:9273:
ROE %: 16.50% (31% above median its 10-year median of 12.57)
GF Value™: 円752.97 vs. price of 円780.00 (3.6% above fair value)
Industry Position: 173.2% above the Drug Manufacturers median (#462 of 937)
No single metric tells the full story. See the TSE:9273 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Koa Shoji Holdings Co Ltd is a pharmaceutical manufacturing company. It is mainly engaged in the manufacturing, sales, and import/export of pharmaceuticals.
83GF Score
Get the complete analysis for TSE:9273
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9273 has been successfully added to your 
